BEBuffy S. Ellsworth

Buffy S. Ellsworth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Buffy S. Ellsworth has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Deborah O. Jung

    Department of Physiology, Southern Illinois University, Carbondale, Illinois, United States of America

    4 shared publications
  • Brock E. Kabat

    Department of Physiology, Southern Illinois University, Carbondale, Illinois, United States of America

    2 shared publications
  • Corrie L. Farris

    Department of Physiology, Southern Illinois University, Carbondale, Illinois

    2 shared publications
  • Adam G Ploegman

    Department of Physiology, Southern Illinois University, Carbondale, Illinois, United States of America

    1 shared publication
  • Adam Gerrit Ploegman

    1 shared publication
  • Amy M Navratil

    Department of Zoology and Physiology, University of Wyoming, Laramie, Wyoming, United States of America

    1 shared publication

Latest Publications

  • Pituitary Regeneration: It'll Knock Your SOX Off!

    by Buffy S. Ellsworth

    Article published by the Endocrine Society Article published by the Endocrine Society


  • Open Access

    Loss of Foxm1 Results in Reduced Somatotrope Cell Number during Mouse Embryogenesis

    by Michael J Calderon, Adam G Ploegman, Brock Bailey, Deborah O Jung, Amy M Navratil, Buffy S Ellsworth

    FOXM1, a member of the forkhead box transcription factor family, plays a key role in cell cycling progression by regulating the expression of critical G1/S and G2/M phase transition genes. In vivo studies reveal that Foxm1 null mice have a 91% lethality rate at e18.5 due to significant cardiovascular and hepatic hypoplasia. Thus, FOXM1 has emerged as a key protein regulating mitotic division and cell proliferation necessary for embryogenesis. In the current study, we assess the requirement for Foxm1 in the developing pituitary gland. We find that Foxm1 is expressed in the pituitary at embryonic days 10.5-e18.5 and localizes with markers for active cell proliferation (BrdU). Interestingly, direct analysis of Foxm1 null mice at various embryonic ages, reveals no difference in gross pituitary morphology or cell proliferation. We do observe a downward trend in overall pituitary cell number and a small reduction in pituitary size in e18.5 embryos suggesting there may be subtle changes in pituitary proliferation not detected with our proliferation makers. Consistent with this, Foxm1 null mice have reductions in both the somatotrope and gonadotrope cell populations.


  • Open Access

    The Forkhead Transcription Factor, FOXP3: A Critical Role in Male Fertility in Mice1

    by Jake S. Jasurda, Deborah O. Jung, Erin D. Froeter, David B. Schwartz, Torin D. Hopkins, Corrie L. Farris, Stacey McGee, Prema Narayan, Buffy S. Ellsworth

    Fertility is dependent on the hypothalamic-pituitary-gonadal axis. Each component of this axis is essential for normal reproductive function. Mice with a mutation in the forkhead transcription factor gene, Foxp3, exhibit autoimmunity and infertility. We have previously shown that Foxp3 mutant mice have significantly reduced expression of pituitary gonadotropins. To address the role of Foxp3 in gonadal function, we examined the gonadal phenotype of these mice. Foxp3 mutant mice have significantly reduced seminal vesicle and testis weights compared with Foxp3+/Y littermates. Spermatogenesis in Foxp3 mutant males is arrested prior to spermatid elongation. Activation of luteinizing hormone signaling in Foxp3 mutant mice by treatment with human chorionic gonadotropin significantly increases seminal vesicle and testis weights as well as testicular testosterone content and seminiferous tubule diameter. Interestingly, human chorionic gonadotropin treatments rescue spermatogenesis in Foxp3 mutant males, suggesting that their gonadal phenotype is due primarily to a loss of pituitary gonadotropin stimulation rather than an intrinsic gonadal defect.


  • Obesity: A Somatotrope Perspective

    by Buffy S. Ellsworth


  • Open Access

    The Forkhead Transcription Factor, Foxd1, Is Necessary for Pituitary Luteinizing Hormone Expression in Mice

    by Jason H. Gumbel, Elizabeth M. Patterson, Sarah A. Owusu, Brock E. Kabat, Deborah O. Jung, Jasmine Simmons, Torin Hopkins, Buffy S. Ellsworth

    The pituitary gland regulates numerous physiological functions including growth, reproduction, temperature and metabolic homeostasis, lactation, and response to stress. Pituitary organogenesis is dependent on signaling factors that are produced in and around the developing pituitary. The studies described in this report reveal that the forkhead transcription factor, Foxd1, is not expressed in the developing mouse pituitary gland, but rather in the mesenchyme surrounding the pituitary gland, which is an essential source of signaling factors that regulate pituitary organogenesis. Loss of Foxd1 causes a morphological defect in which the anterior lobe of the pituitary gland protrudes through the cartilage plate that is developing ventral to the pituitary at embryonic days (e)14.5, e16.5, and e18.5. The number of proliferating pituitary cells is increased at e14.5 and e16.5. Loss of Foxd1 also results in significantly decreased levels of Lhb expression at e18.5. This decrease in Lhb expression does not appear to be due to a change in the number of gonadotrope cells in the pituitary gland. Previous studies have shown that loss of the LIM homeodomain factor, Lhx3, which is activated by the FGF signaling pathway, results in loss of LH production. Although there is a difference in Lhb expression in Foxd1 null mice, the expression pattern of LHX3 is not altered in Foxd1 null mice. These studies suggest that Foxd1 is indirectly required for normal Lhb expression and cartilage formation.


  • Open Access

    Forkhead Box O1 Is Present in Quiescent Pituitary Cells during Development and Is Increased in the Absence of p27Kip1

    by Sreeparna Majumdar, Corrie L. Farris, Brock E. Kabat, Deborah O. Jung, Buffy S. Ellsworth

    Congenital pituitary hormone deficiencies have been reported in approximately one in 4,000 live births, however studies reporting mutations in some widely studied transcription factors account for only a fraction of congenital hormone deficiencies in humans. Anterior pituitary hormones are required for development and function of several glands including gonads, adrenals, and thyroid. In order to identify additional factors that contribute to human congenital hormone deficiencies, we are investigating the forkhead transcription factor, FOXO1, which has been implicated in development of several organs including ovary, testis, and brain. We find that FOXO1 is present in the nuclei of non-dividing pituitary cells during embryonic development, consistent with a role in limiting proliferation and/or promoting differentiation. FOXO1 is present in a subset of differentiated cells at e18.5 and in adult with highest level of expression in somatotrope cells. We detected FOXO1 in p27Kip1-positive cells at e14.5. In the absence of p27Kip1 the number of pituitary cells containing FOXO1 is significantly increased at e14.5 suggesting that a feedback loop regulates the interplay between FOXO1 and p27Kip1.


  • The Role of the Forkhead Transcription Factor, FOXM1, in Pituitary Gland Development

    by Adam Gerrit Ploegman, Buffy S Ellsworth

    The central goal of our studies is to understand the molecular mechanisms that govern pituitary gland development. We have found that the forkhead transcription factor, FOXM1, is expressed in the developing mouse pituitary. FOXM1 promotes genes that push the cell into mitosis through G1/S phase and G2/M phase checkpoints by regulating the expression of targets such as Cyclin D, Cyclin B and Cdc25b. Also, FOXM1 has been linked to cell migration, via proteins MMP-2 and MMP-9, which are matrix metalloproteinases. We observed that FOXM1 co-localizes with proliferation markers such as BrdU in wild-type mouse embryos at ages e12.5 through e16.5 as well as with as a subset of cells that express Ki67 at ages e14.5 and e16.5, but not with the cell cycle inhibitors p27Kip1 and p57Kip2. This identifies FOXM1 expression in proliferating, non-differentiated pituitary cells. To assess the role of FOXM1 during pituitary gland development, we have acquired Foxm1b knockout mice. We are particularly interested in FOXM1's effect on pituitary morphology and function. To visualize pituitary morphology, we performed hematoxylin and eosin staining on Foxm1b null and wild-type embryos at ages e10.5, e12.5, e14.5, and e16.5, and determined that the pituitary does not appear to be hypoplastic. To investigate pituitary function we are using immunohistochemistry to label pituitary hormones. We found that FOXM1 is not required for production of ACTH. These studies should elucidate the importance of FOXM1 in the developing pituitary. Nothing to Disclose: AGP, BSE